who owns the patent for semaglutide Story: How One Molecule Re‑wired Obesity, Patents and Pharma Profits Ozempic just got much, much

Mounjaro Most GLP-1 medications have shown kidney benefits, but semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound) have the strongest clinical evidence for slowing kidney disease progression

Novel Drug Delivery Technologies Hydrogel Depot Technology Hydrogel depot technology uses injectable hydrogels to create a reservoir or depot at the injection site, allowing for sustained and controlled release of therapeutic substances over time

The drugs molecular structure has been public for years, since Eli Lilly published it in a research paper in 2022

2C or not 2C: defining an improved revascularization grading scale and the need for standardization of angiography outcomes in stroke trials